Baird Maintains Outperform on Owens & Minor, Lowers Price Target to $62
Baird analyst Eric Coldwell maintains Owens & Minor (NYSE:OMI) with a Outperform and lowers the price target from $70 to $62.
This Biotechnology Stock Jumped Over 360%; Here Are 106 Biggest Movers From Yesterday
Gainers
Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) shares surged 360.5% to settle at $19.80 on Wednesday on above-average volume.
Why Poseida Therapeutics Almost Doubled Today, Here Are 75 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Helius Medical Technologies, Inc. (NASDAQ: HSDT) shares jumped 167% to $1.72 after dropping 13% on Tuesday.
AMD, SolarEdge Technologies And Some Other Big Stocks Moving Lower On Wednesday
Rocky Brands, Inc. (NASDAQ: RCKY) dipped 21.6% to $26.62 after the company reported worse-than-expected Q2 EPS results.
Owens & Minor Shares Slip On FY22 Outlook Cut
Owens & Minor Inc (NYSE:OMI) reported second-quarter revenue of $2.50 billion, an increase of 0.44% year-over-year, missing the consensus of…
Recap: Owens & Minor Q2 Earnings
Owens & Minor (NYSE:OMI) reported its Q2 earnings results on Wednesday, August 3, 2022 at 06:45 AM.
Here's what investors need to know about the announcement.
Earnings
Owens & Minor reported in-line EPS of $0.76 versus an estimate of $0.76.
MIMEDX Issues Letter To Shareholders
Highlights Successful Execution of Transformation Strategy Under CEO Tim Wright
Reaffirms Commitment to Enhancing Value for ALL Shareholders
Urges Shareholders to Vote “FOR” Both of MIMEDX’s Highly
Recap: Owens & Minor Q1 Earnings
Owens & Minor (NYSE:OMI) reported its Q1 earnings results on Tuesday, May 3, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
Owens & Minor beat estimated earnings by 17.07%, reporting an EPS of $0.96 versus an estimate of $0.82.